Karsberg, Sidsel
Hesse, Morten
Pedersen, Michael Mulbjerg
Charak, Ruby
Pedersen, Mads Uffe
Article History
Received: 10 September 2020
Accepted: 16 February 2021
First Online: 8 March 2021
Declarations
:
: The clinical trial was approved by the Danish Data Protection Agency and the Regional Committee for Medical and Health Research Ethics for the Central Denmark Region (project number: 48271). All participants signed an informed consent form. Due to the low risk and nature of the intervention, dispensation and approval was given by the Regional Committee for Medical and Health Research Ethics – Central Denmark Region, so that adolescents aged 15 to 17 years could provide informed consent. For these adolescents, parents were informed about the treatment. The study was carried out in accordance with the Declaration of Helsinki, and good clinical practice.
: Not applicable.
: There are no competing interests to declare.